Basit öğe kaydını göster

dc.contributor.authorHatemi, Gülen
dc.contributor.authorYAZICI, Yılmaz
dc.contributor.authorOZGULER, Yeşim
dc.contributor.authorYAZICI, H
dc.date.accessioned2021-03-03T17:07:12Z
dc.date.available2021-03-03T17:07:12Z
dc.identifier.citationYAZICI H., OZGULER Y., Hatemi G., YAZICI Y., "Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.", Arthritis care & research, cilt.68, ss.724, 2016
dc.identifier.issn2151-464X
dc.identifier.othervv_1032021
dc.identifier.otherav_48098c05-7baf-43f3-a76a-afa7c9adcf89
dc.identifier.urihttp://hdl.handle.net/20.500.12627/51943
dc.identifier.urihttps://doi.org/10.1002/acr.22863
dc.language.isoeng
dc.titleRecommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.
dc.typeMakale
dc.relation.journalArthritis care & research
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume68
dc.identifier.startpage724
dc.identifier.endpage724
dc.contributor.firstauthorID159766


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster